Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-1996 | 08-1993 | 08-1992 | 08-1991 | 08-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 527 | -3,304 | 918 | 1,178 | 1,211 |
| Depreciation Amortization | 1,293 | 545 | 482 | 501 | 405 |
| Other Working Capital | -2,392 | 684 | -4,251 | 586 | -1,204 |
| Other Operating Activity | 173 | 899 | 390 | -237 | 308 |
| Operating Cash Flow | $-399 | $-1,176 | $-2,461 | $2,028 | $720 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,567 | -511 | -565 | -491 | -649 |
| Net Acquisitions | 0 | N/A | -245 | N/A | N/A |
| Investing Cash Flow | $-2,567 | $-511 | $-810 | $-491 | $-649 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -67 | N/A | N/A | -195 | -240 |
| Other Financing Activity | 2,490 | 1,840 | 3,973 | -1,224 | 216 |
| Financing Cash Flow | $2,423 | $1,840 | $3,973 | $-1,419 | $-24 |
| Beginning Cash Position | 632 | 1,154 | 452 | 95 | 48 |
| End Cash Position | 111 | 1,307 | 1,154 | 213 | 95 |
| Net Cash Flow | $-521 | $153 | $702 | $118 | $47 |
| Free Cash Flow | |||||
| Operating Cash Flow | -399 | -1,176 | -2,461 | 2,028 | 720 |
| Free Cash Flow | -399 | -1,176 | -2,461 | 2,028 | 720 |